IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test kits. The company also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, it offers diagnostic tests, services, and related instrumentation for manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

IDEXX Laboratories Inc.

Idexx Laboratories ( ($IDXX) ) has released its Q3 earnings. Here is a breakdown of the information Idexx Laboratories presented to its investors. ...

IDEXX Laboratories Reports Strong Q3 2025 Results

In a report released yesterday, Jonathan Block from Stifel Nicolaus upgraded Idexx Laboratories to a Buy, with a price target of $700.00. The compa...

Current Quarter	$2.93	Next Quarter	$3.39
Current Year	$12.93	Next Year	$14.42
QoQ Growth	+15.7%	YoY Growth	+11.5%
3Y EPS CAGR	+7.2%	Target Price	$785.27
Consensus	Buy	Upside	+8.2%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	IDXX	$725.91	+5.30%	972.62K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	IDXX	$725.91	+5.3%	972.62K
3
4
5
6

IDXX

IDXX

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get IDEXX Laboratories Inc. Data in Excel

Get IDEXX Laboratories Inc. Data in Excel